Sensei Biotherapeutics, Inc.
Related Filers (27)
- Cambrian BioPharma Inc (57)
- Peyer James (56)
- Apeiron Investment Group Ltd. (11)
- Celebi John (8)
- Pierce Robert Hamilton (7)
- Colgan Erin (7)
- RICKS THOMAS G (6)
- Gallagher Patrick Stephen (5)
- Broder Samuel (4)
- Vojta Deneen (4)
- Humer Kristian (4)
- Holmen Bob (4)
- English Jessie (4)
- van der Horst Edward (4)
- H INVESTMENTS I LP (3)
- Presight Co-Invest Management, L.L.C. (3)
- Angermayer Christian (3)
- RINGO WILLIAM R (3)
- Fjaellskog Marie-Louise (2)
- Hoey Anupama (2)
- SCHULMAN MICHAEL (2)
- H VENTURES LLC (2)
- SAMUELI HENRY (2)
- SAMUELI SUSAN (2)
- Presight Sensei Co-Invest Fund, L.P. (2)
- Krebs Stephanie (2)
- Newtyn Management, LLC (2)
- Show More ...
Financials (13)
10-Q
Tuesday, 11/7/2023
Quarterly Report for period ending 2023-09-30
10-Q
Thursday, 8/3/2023
Quarterly Report for period ending 2023-06-30
10-Q
Tuesday, 5/9/2023
Quarterly Report for period ending 2023-03-31
10-K/A
Monday, 5/1/2023
Annual Report for period ending 2022-12-31
10-K
Wednesday, 3/29/2023
Annual Report for period ending 2022-12-31
10-Q
Tuesday, 11/8/2022
Quarterly Report for period ending 2022-09-30
10-Q
Tuesday, 8/9/2022
Quarterly Report for period ending 2022-06-30
10-Q
Tuesday, 5/10/2022
Quarterly Report for period ending 2022-03-31
10-K
Tuesday, 3/15/2022
Annual Report for period ending 2021-12-31
10-Q
Wednesday, 11/10/2021
Quarterly Report for period ending 2021-09-30
10-Q
Wednesday, 8/11/2021
Quarterly Report for period ending 2021-06-30
10-Q
Thursday, 5/13/2021
Quarterly Report for period ending 2021-03-31
10-K
Tuesday, 3/30/2021
Annual Report for period ending 2020-12-31
News (44)
8-K
Thursday, 2/8/2024
Current report filing
8-K
Thursday, 1/4/2024
Current report filing
8-K
Tuesday, 11/7/2023
Current report filing
8-K
Monday, 11/6/2023
Current report filing
8-K
Friday, 11/3/2023
Current report filing
8-K
Friday, 10/20/2023
Current report filing
8-K
Thursday, 8/3/2023
Current report filing
8-K
Monday, 7/10/2023
Current report filing
8-K
Tuesday, 6/27/2023
Current report filing
8-K
Friday, 6/23/2023
Current report filing
8-K
Tuesday, 5/23/2023
Current report filing
8-K
Tuesday, 5/9/2023
Current report filing
8-K
Thursday, 4/20/2023
Current report filing
8-K
Tuesday, 3/28/2023
Current report filing
8-K
Monday, 3/13/2023
Current report filing
8-K
Friday, 3/10/2023
Current report filing
8-K
Tuesday, 3/7/2023
Current report filing
8-K
Monday, 2/6/2023
Current report filing
8-K
Friday, 12/9/2022
Current report filing
8-K
Thursday, 12/8/2022
Current report filing
8-K
Thursday, 11/10/2022
Current report filing
8-K
Tuesday, 11/8/2022
Current report filing
8-K
Friday, 9/30/2022
Current report filing
8-K
Wednesday, 8/31/2022
Current report filing
8-K
Tuesday, 8/9/2022
Current report filing
8-K
Tuesday, 6/14/2022
Current report filing
8-K
Tuesday, 5/10/2022
Current report filing
8-K
Wednesday, 4/20/2022
Current report filing
8-K
Thursday, 3/10/2022
Current report filing
8-K
Wednesday, 3/9/2022
Current report filing
8-K
Monday, 1/10/2022
Current report filing
8-K
Monday, 12/6/2021
Current report filing
8-K
Tuesday, 11/16/2021
Current report filing
8-K
Tuesday, 11/9/2021
Current report filing
8-K
Wednesday, 9/8/2021
Current report filing
8-K
Wednesday, 8/4/2021
Current report filing
8-K
Monday, 8/2/2021
Current report filing
8-K
Monday, 6/28/2021
Current report filing
8-K
Thursday, 6/17/2021
Current report filing
8-K
Wednesday, 5/12/2021
Current report filing
8-K
Monday, 5/3/2021
Current report filing
8-K
Monday, 4/5/2021
Current report filing
8-K
Thursday, 3/25/2021
Current report filing
8-K
Thursday, 2/11/2021
Current report filing
Other (14)
ARS
Thursday, 6/15/2023
Annual report to security holders
8-A12B
Tuesday, 3/7/2023
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
EFFECT
Monday, 5/9/2022
Notice of Effectiveness
CORRESP
Friday, 5/6/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 5/6/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 5/4/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CERT
Wednesday, 2/3/2021
Certification by an exchange approving securities for listing
EFFECT
Wednesday, 2/3/2021
Notice of Effectiveness
8-A12B
Tuesday, 2/2/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Monday, 2/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 2/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 1/22/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 1/15/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Tuesday, 12/29/2020
None
Ownership (195)
4
Friday, 2/16/2024
van der Horst Edward: Statement of changes in beneficial ownership of securities
4
Friday, 2/16/2024
Colgan Erin: Statement of changes in beneficial ownership of securities
4
Friday, 2/16/2024
Celebi John: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 2/13/2024
Newtyn Management, LLC: Major Shareholders
SC 13D
Friday, 11/3/2023
Newtyn Management, LLC: Major Shareholders
3
Thursday, 11/2/2023
Krebs Stephanie: Initial statement of beneficial ownership of securities
4
Thursday, 11/2/2023
Krebs Stephanie: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/13/2023
Celebi John: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2023
Gallagher Patrick Stephen: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2023
van der Horst Edward: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2023
Celebi John: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2023
Colgan Erin: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 8/4/2023
Cambrian BioPharma Inc: Major Shareholders
4
Wednesday, 8/2/2023
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/2/2023
Peyer James: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Broder Samuel: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
RICKS THOMAS G: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
RINGO WILLIAM R: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Vojta Deneen: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Humer Kristian: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Peyer James: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Holmen Bob: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
English Jessie: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 6/2/2023
Apeiron Investment Group Ltd.: Major Shareholders
4
Friday, 6/2/2023
Presight Sensei Co-Invest Fund, L.P.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 5/23/2023
Apeiron Investment Group Ltd.: Major Shareholders
4/A
Wednesday, 3/29/2023
Gallagher Patrick Stephen: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 3/29/2023
Celebi John: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 3/29/2023
Colgan Erin: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 3/9/2023
Apeiron Investment Group Ltd.: Major Shareholders
4/A
Tuesday, 3/7/2023
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2023
Presight Sensei Co-Invest Fund, L.P.: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
Celebi John: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
Gallagher Patrick Stephen: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
van der Horst Edward: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
Colgan Erin: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Cambrian BioPharma Inc: Major Shareholders
3
Friday, 12/16/2022
van der Horst Edward: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 11/21/2022
Apeiron Investment Group Ltd.: Major Shareholders
SC 13D/A
Wednesday, 11/2/2022
Apeiron Investment Group Ltd.: Major Shareholders
4/A
Thursday, 9/1/2022
Pierce Robert Hamilton: Statement of changes in beneficial ownership of securities
4/A
Monday, 8/1/2022
Peyer James: Statement of changes in beneficial ownership of securities
3/A
Monday, 8/1/2022
Peyer James: Initial statement of beneficial ownership of securities
3
Wednesday, 7/20/2022
Apeiron Investment Group Ltd.: Initial statement of beneficial ownership of securities
SC 13D
Tuesday, 7/19/2022
Apeiron Investment Group Ltd.: Major Shareholders
4
Tuesday, 6/14/2022
RICKS THOMAS G: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Holmen Bob: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
English Jessie: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Vojta Deneen: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Humer Kristian: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Broder Samuel: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4/A
Friday, 6/10/2022
Peyer James: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 6/10/2022
Cambrian BioPharma Inc: Major Shareholders
4/A
Friday, 6/10/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
Gallagher Patrick Stephen: Statement of changes in beneficial ownership of securities
3
Friday, 6/3/2022
Gallagher Patrick Stephen: Initial statement of beneficial ownership of securities
4/A
Thursday, 4/21/2022
Peyer James: Statement of changes in beneficial ownership of securities
4/A
Thursday, 4/21/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4/A
Thursday, 4/21/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4/A
Thursday, 4/21/2022
Peyer James: Statement of changes in beneficial ownership of securities
3
Wednesday, 3/9/2022
RINGO WILLIAM R: Initial statement of beneficial ownership of securities
4
Wednesday, 3/9/2022
RINGO WILLIAM R: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/1/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/1/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Monday, 2/28/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Monday, 2/28/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 2/24/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 2/24/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/22/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/22/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 2/17/2022
Pierce Robert Hamilton: Statement of changes in beneficial ownership of securities
4
Thursday, 2/17/2022
Celebi John: Statement of changes in beneficial ownership of securities
4
Thursday, 2/17/2022
Colgan Erin: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/16/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/16/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Monday, 2/14/2022
Peyer James: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 2/14/2022
H INVESTMENTS I LP: Major Shareholders
4
Monday, 2/14/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/10/2022
Apeiron Investment Group Ltd.: Major Shareholders
4
Tuesday, 2/8/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/8/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Monday, 1/31/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Monday, 1/31/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 1/27/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 1/27/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/25/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/25/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 1/20/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 1/20/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/18/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/18/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
Prospectus (14)
424B5
Thursday, 8/17/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Wednesday, 3/29/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Tuesday, 5/10/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Monday, 5/9/2022
Prospectus filed pursuant to Rule 424(b)(5)
S-3/A
Monday, 5/9/2022
Registration statement for specified transactions by certain issuers
S-3
Tuesday, 3/15/2022
Registration statement for specified transactions by certain issuers
S-8
Wednesday, 2/10/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Thursday, 2/4/2021
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Wednesday, 2/3/2021
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Monday, 2/1/2021
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 1/15/2021
General form of registration statement for all companies including face-amount certificate companies
DRSLTR
Tuesday, 12/22/2020
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 12/22/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Thursday, 11/12/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (6)
DEF 14A
Thursday, 6/15/2023
Definitive proxy statements
DEFA14A
Tuesday, 5/23/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Friday, 3/10/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Thursday, 4/28/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Thursday, 4/28/2022
Definitive proxy statements
DEFA14A
Thursday, 4/28/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.